Clinical Trial Update: Randomized, Double-blind, Crossover, Pharmacokinetic (PK) and Glucodynamic (GD) Study of Continuous Subcutaneous Insulin Infusion (CSII) in Participants With Type 1 Diabetes Mellitus (T1DM) [Phase 1]

View source ↗

Summary

Phase 1 randomized, double-blind, crossover PK and glucodynamic study evaluating continuous subcutaneous insulin infusion in participants with Type 1 Diabetes M…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: Halozyme Therapeutics | Conditions: Type 1 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2014-07-25